LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study
Poordad, F., Schiff, E.R., Vierling, J.M., Landis, C., Fontana, R.J., Yang, R., McPhee, F., Hughes, E., Noviello, S., Swenson, E.S.Volume:
62
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(15)30154-9
Date:
April, 2015
File:
PDF, 123 KB
english, 2015